Registry of Lobbyists
Total Number of Communication Reports: 1
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Economic Development, Health, Infrastructure
|
Engage with the federal government on building Canada's vaccine and biomanufacturing ecosystem.
|
Policies or Program
|
|
Economic Development, Health, Infrastructure
|
Seeking funding from the Strategic Innovation Fund to allow for the construction of facilities to advance Canada’s vaccine and biomanufacturing capabilities.
|
Grant, Contribution or Other Financial Benefit
|
Resilience Biotechnologies (RBI), formerly Therapure Biopharma, is a wholly owned subsidiary of National Resilience, Inc. RBI is an Ontario-based Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of complex biologics. RBI’s mission is to support for Canadian vaccine and therapeutics production and serve as a long-term partner for Canadian pharmaceutical manufacturing.
Sankalp Vashishtha, Vice President / General Manager
Address:
2585 Meadowpine Blvd.
Mississauga, ON L5N 8H9
Canada
Telephone number:
905-286-6200
Resilience Biotechnologies, Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking